We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
-0.63%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$150M
AUM Growth
-$19.5M
Cap. Flow
-$10.6M
Cap. Flow %
-7.05%
Top 10 Hldgs %
52.92%
Holding
99
New
9
Increased
16
Reduced
55
Closed
13

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$1.62M
2
LLY icon
Eli Lilly
LLY
+$1.28M
3
HCAT icon
Health Catalyst
HCAT
+$1.27M
4
PRVA icon
Privia Health
PRVA
+$1.03M
5
CLOV icon
Clover Health Investments
CLOV
+$983K

Top Sells

Rank Stock Value
1
IQV icon
IQVIA
IQV
+$1.8M
2
ZBH icon
Zimmer Biomet
ZBH
+$1.46M
3
ICLR icon
Icon
ICLR
+$1.32M
4
EW icon
Edwards Lifesciences
EW
+$1.26M
5
OPCH icon
Option Care Health
OPCH
+$1.25M

Sector Composition

Rank Sector Weight
1 Healthcare 99.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ILMN icon
51
Illumina
ILMN
$31B
$584K 0.39%
4,370
-1,375
-24% -$196K
EW icon
52
Edwards Lifesciences
EW
$49.6B
$581K 0.39%
7,850
-18,000
-70% -$1.26M
ARVN icon
53
Arvinas
ARVN
$518M
$578K 0.39%
30,150
-15,680
-34% -$381K
COGT icon
54
Cogent Biosciences
COGT
$6.65B
$576K 0.38%
73,800
-10,600
-13% -$106K
SMMT icon
55
Summit Therapeutics
SMMT
$10.4B
$535K 0.36%
30,000
+3,300
+12% +$64K
ENGN icon
56
enGene Therapeutics
ENGN
$120M
$525K 0.35%
78,919
-15,300
-16% -$119K
INSM icon
57
Insmed
INSM
$21.4B
$509K 0.34%
7,371
-2,310
-24% -$166K
RCKT icon
58
Rocket Pharmaceuticals
RCKT
$340M
$505K 0.34%
40,183
-3,200
-7% -$48.2K
ITCI
59
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$409K 0.27%
4,900
-1,530
-24% -$126K
ROIV icon
60
Roivant Sciences
ROIV
$24.5B
$408K 0.27%
34,500
-10,627
-24% -$126K
HUM icon
61
Humana
HUM
$43.7B
$401K 0.27%
1,581
-600
-28% -$161K
ONC
62
BeOne Medicines Ltd
ONC
$32.8B
$371K 0.25%
2,010
-627
-24% -$128K
OLMA icon
63
Olema Pharmaceuticals
OLMA
$1B
$359K 0.24%
61,650
-4,330
-7% -$43.2K
BBIO icon
64
BridgeBio Pharma
BBIO
$15.7B
$316K 0.21%
11,500
-3,585
-24% -$92.6K
MEDP icon
65
Medpace
MEDP
$16.1B
$276K 0.18%
830
-256
-24% -$86.8K
PTCT icon
66
PTC Therapeutics
PTCT
$5.68B
$262K 0.17%
5,800
-1,800
-24% -$77K
TSBX
67
DELISTED
Turnstone Biologics
TSBX
$257K 0.17%
517,648
– –
IONS icon
68
Ionis Pharmaceuticals
IONS
$8.6B
$252K 0.17%
7,200
-2,240
-24% -$83.7K
VERA icon
69
Vera Therapeutics
VERA
$2.3B
$241K 0.16%
5,700
-1,728
-23% -$76.5K
CRNX icon
70
Crinetics Pharmaceuticals
CRNX
$8.84B
$225K 0.15%
4,400
-1,400
-24% -$78.3K
GERN icon
71
Geron
GERN
$828M
$225K 0.15%
63,500
+17,500
+38% +$69.9K
ASND icon
72
Ascendis Pharma A/S
ASND
$16B
$220K 0.15%
1,600
-541
-25% -$71.1K
JAZZ icon
73
Jazz Pharmaceuticals
JAZZ
$15.9B
$216K 0.14%
1,750
-524
-23% -$61.8K
RVMD icon
74
Revolution Medicines
RVMD
$39.9B
$214K 0.14%
4,900
-1,530
-24% -$77.2K
UTHR icon
75
United Therapeutics
UTHR
$25.8B
$210K 0.14%
595
-465
-44% -$171K
1 2
3
4

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q4 2024 Portfolio in Review

As of Q4 2024, Sectoral Asset Management held 99 positions worth $150M, down 12% from $169M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Sectoral Asset Management withdrew a net $10.6M in Q4 2024, closing 13 positions and reducing 55 holdings. Its most notable exit was IQVIA, an estimated $1.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 99% a quarter earlier.

Against the trend, Sectoral Asset Management opened a new position in Health Catalyst worth $1.13M.

  • Sectoral Asset Management's largest Q4 2024 buy was Health Catalyst: 160,000 shares worth $1.13M.
  • Sectoral Asset Management added most to Amgen in Q4 2024, an estimated $1.62M increase.
  • Sectoral Asset Management's biggest Q4 2024 reduction was Edwards Lifesciences, cutting an estimated $1.26M.
  • Sectoral Asset Management fully exited IQVIA in Q4 2024, selling an estimated $1.8M.
  • Sectoral Asset Management's ten largest holdings make up 53% of its $150M portfolio in Q4 2024.
  • Sectoral Asset Management opened 9 new positions and closed 13 in Q4 2024.
  • Sectoral Asset Management's portfolio value fell 12% quarter-over-quarter to $150M.

Based on Sectoral Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.